Treatment with the experimental immune-modulating therapy vidofludimus calcium reduced disease activity on MRI scans in adults with relapsing-remitting multiple sclerosis (RRMS), data from the Phase 2 EMPhASIS clinical trial shows.
The MYTHS of MS There is no one description of MS that covers all
A large array of MS information stemming from Living with MS physically and emotional to financial security to relationships
Multiple sclerosis (MS) is a lifelong condition with symptoms such as fatigue, pain, bladder and bowel problems, sexual dysfunction, movement and coordination difficulties, vision and cognition changes, and emotional/mental health problems.
Scientists have uncovered new clues implicating a type of herpes virus as the cause of a central nervous system
MS is a lifelong disease, so it’s important to be under the care of an MS specialist who is a good match for you
Disease-modifying therapies (DMTs) can prevent acute MS attacks, or relapses, and slow the progression of the disease, thereby preventing physical and cognitive disability. Other drugs, primarily corticosteroids, are used to help control severe symptoms during relapses.
n many chronic conditions, the way the disease will progress over months or years is relatively predictable. That’s not the case with multiple sclerosis (MS); while some people with the disease may be only mildly impacted over years or even decades, others may lose their ability to walk, speak, or swallow over time. And many are affected cognitively, meaning their ability to think, focus, and remember may be impaired, making it difficult to hold down a job.
A drug that treats relapsing-remitting multiple sclerosis – a form of multiple sclerosis that accounts for around 85 percent of people with the condition – has been revealed to reverse some of the damage caused by the disease. This revelation may have implications for future therapeutic strategies for people with the neurological disease.
